Literature DB >> 23932095

TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case study.

Andrzej Semczuk1, Piotr K Zakrzewski, Ewa Forma, Adam I Cygankiewicz, Anna Semczuk-Sikora, Magdalena Bryś, Tomasz Rechberger, Wanda M Krajewska.   

Abstract

Data assessing the role of various genetic alterations in uterine carcinosarcoma (CS), particularly the transforming growth factors-β (TGFβ) that play a crucial role in many cellular processes, including proliferation, differentiation, adhesion and migration, are scarce. TGFβ exert their effects through specific receptors and associated auxiliary receptors. In the current study, we investigated the expression of TGFβ isoforms and their receptors, as well as selected genes in a case of CS. We applied the real-time fluorescence detection PCR method with FAM dye-labeled TaqMan specific probes. In a comparison to the normal counterpart, TGFB1, TGFB2, TGFBRII, TGFBR3, ENG and CD109 were all down-regulated in uterine CS samples at different extents. BIRC5 and hTERT, markers of tumor survival, were up-regulated in CS as compared with normal counterparts. A concomitant increase of the hypoxia marker HIF1A expression pattern was noted, whereas the expression of GPR120, responsible for free fatty acids sensing, was not different in both counterparts evaluated. In conclusion, deregulation of various cellular mechanisms in uterine CS is associated with alterations at many levels - cell growth and proliferation, apoptosis, and impaired response to stimuli from extracellular environment.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CS; DγC; EC; LVSI; RT-PCR; TGFβ; Uterine carcinosarcoma; carcinosarcoma; dilatation and curettage; endometrial cancer; lymphovascular space invasion

Mesh:

Substances:

Year:  2013        PMID: 23932095     DOI: 10.1016/j.prp.2013.06.017

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.

Authors:  Ruijing Lu; Ziliang Ji; Xiaoqing Li; Jie Qin; Guanghui Cui; Jing Chen; Qingna Zhai; Chunjuan Zhao; Wei Zhang; Zhendong Yu
Journal:  Tumour Biol       Date:  2015-03-27

2.  Inter-component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma.

Authors:  Andrzej Pyra; Aneta Adamiak-Godlewska; Dorota Lewkowicz; Beata Bałon; Marek Cybulski; Anna Semczuk-Sikora; Andrzej Semczuk
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111

3.  Down-regulated microRNA-141 facilitates osteoblast activity and inhibits osteoclast activity to ameliorate osteonecrosis of the femoral head via up-regulating TGF-β2.

Authors:  Lei Tian; Shui Sun; Wei Li; Lin Yuan; Xianquan Wang
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

4.  Carcinosarcoma with Choriocarcinomatous and Osteosarcomatous Differentiation in a Patient with Juvenile Polyposis Syndrome.

Authors:  Rafael Parra-Medina; Patricia López Correa; Julian Jiménez Moreno; Paula Moreno Lucero; Edgardo Yaspe; Fernando Polo
Journal:  Rare Tumors       Date:  2015-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.